Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

79.34
-2.7600-3.36%
Post-market: 79.340.00000.00%17:36 EDT
Volume:4.87M
Turnover:386.99M
Market Cap:46.04B
PE:43.36
High:81.84
Open:81.80
Low:78.57
Close:82.10
52wk High:87.89
52wk Low:65.94
Shares:580.30M
Float Shares:574.00M
Volume Ratio:1.10
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.83
EPS(LYR):1.83
ROE:10.35%
ROA:7.65%
PB:4.45
PE(LYR):43.29

Loading ...

Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating

MT Newswires Live
·
Feb 11

Edwards Lifesciences price target lowered to $95 from $108 at Goldman Sachs

TIPRANKS
·
Feb 11

Edwards Lifesciences price target raised to $100 from $98 at Piper Sandler

TIPRANKS
·
Feb 11

Edwards Lifesciences Price Target Maintained With a $103.00/Share by BTIG

Dow Jones
·
Feb 11

U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart

Reuters
·
Feb 11

Edwards Lifesciences Corp : Piper Sandler Raises Target Price to $100 From $98

THOMSON REUTERS
·
Feb 11

BUZZ-Edwards Lifesciences gains on upbeat 2026 profit outlook

Reuters
·
Feb 11

Edwards Lifesciences Q4 TMTT sales surge over 40% to USD 156 million

Reuters
·
Feb 11

Edwards Lifesciences Q4 Adj. EPS $0.58 Misses $0.62 Estimate, Sales $1.570B Beat $1.546B Estimate

Benzinga
·
Feb 11

Edwards Lifesciences Corp: Increased Confidence in Meeting 2026 Sales Growth Rate Guidance of 8 to 10% & EPS Guidance of $2.90 to $3.05

THOMSON REUTERS
·
Feb 11

Edwards Lifesciences Outlook Q1 Sales USD 1,550-1,630 Million

THOMSON REUTERS
·
Feb 11

U.S. Earnings Preview: After Market Close Feb. 10

Dow Jones
·
Feb 11

Edwards Lifesciences options imply 5.3% move in share price post-earnings

TIPRANKS
·
Feb 11

Edwards Lifesciences Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 09

Edwards Lifesciences Nears SAPIEN M3 Decision As Big Money Moves

Simply Wall St.
·
Feb 06

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 05

UBS Adjusts Edwards Lifesciences PT to $94 From $95, Maintains Neutral Rating

MT Newswires Live
·
Feb 04

Edwards Lifesciences price target lowered to $94 from $95 at UBS

TIPRANKS
·
Feb 04

Nyse Order Imbalance 213397.0 Shares on Sell Side

THOMSON REUTERS
·
Feb 04